Search Results
NTRK+ NSCLC: Treatment Options and Side Effects - Targeted Therapies in Lung Cancer 2023
Adding to Targeted Therapy: Current Statistics and Biology - Targeted Therapies in Lung Cancer 2023
Improving Clinical Care With Newer Better Therapies for Targeting Actionable gene Fusions in NSCLC
Side Effects of EGFR-TKIs: Pneumonitis and Cardiotoxicity - 2022 Program: Targeted Therapies Forum
Targeted therapies (i.e.: multi-kinase inhibitors, RET, NTRK inhibitors) in advanced disease. 251
Dr Kunal Jobanputra | Updated Analysis of NEJ009 Gefitinib Alone Versus Gefitinib Plus Chemotherapy
Dr Akash Tiwari | Optimal Management of EGFR positive advanced Lung Cancer
Panel discussion | Dr Navneet Singh | Adjuvant Systemic Therapy-TKI
Cancer Education Series: Medical Oncology
Yale Cancer Center Grand Rounds | October 6, 2023
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
